Global Amlodipine Market Growth 2023-2029

March 2023 | 120 pages | ID: G3F03E756D02EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Amlodipine, a calcium antagonist, can be used to treat various types of hypertension (alone or in combination with other drugs) and angina pectoris, especially spontaneous angina pectoris (alone or in combination with other drugs).This product has certain protective effect on kidney.The preparation includes amlodipine benzene sulfonate tablets, amlodipine mesylate tablets, levoamlodipine maleic acid tablets, etc.

LPI (LP Information)' newest research report, the “Amlodipine Industry Forecast” looks at past sales and reviews total world Amlodipine sales in 2022, providing a comprehensive analysis by region and market sector of projected Amlodipine sales for 2023 through 2029. With Amlodipine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amlodipine industry.

This Insight Report provides a comprehensive analysis of the global Amlodipine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amlodipine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Amlodipine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amlodipine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amlodipine.

The global Amlodipine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Amlodipine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Amlodipine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Amlodipine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Amlodipine players cover Novartis, Pfizer, Lek, TEVA, Macleods Pharmaceuticals, Caraco Pharmaceutical, Sanis Health, Jamp Pharma and Accel Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Amlodipine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • by Product
    • Amlodipine Benzene Sulfonate Tablet
    • Amlodipine Mesylate Tablet
    • Levoamlodipine Maleic Acid Tablet
  • by Form
    • Tablets
    • Capsule
Segmentation by application
  • High Blood Pressure
  • Angina Pectoris
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Novartis
  • Pfizer
  • Lek
  • TEVA
  • Macleods Pharmaceuticals
  • Caraco Pharmaceutical
  • Sanis Health
  • Jamp Pharma
  • Accel Pharma
  • Jubilant Generics
  • Angita Pharma
  • Florida DOH Central Pharmacy
  • Shanghai Disainuo Biopharmaceutical
  • Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical
  • Beijing Wansheng Pharmaceutical
  • Beijing Honglin Pharmaceutical
  • Beijing Maidihai Pharmaceutical
  • China Resources Saike Pharmaceutical
  • Beijing Jiulong Pharmaceutical
  • Tiannian Pharmaceutical
  • Chengdu Diao Pharmaceutical Group
  • Yangtze Pharmaceutical
  • Kunming Sino Pharmaceutical
  • Wuhan Dongxin Pharmaceutical Technology
  • Jiangsu Wangao Pharmaceutical
  • Jiangsu Lianhuan Pharmaceutical
  • Jiangsu Huanghe Pharmaceutical
  • Zhejiang Jingxin Pharmaceutical
  • Zhejiang Jianfeng Pharmaceutical
  • Hunan Qianjinxieli Pharmaceutical
Key Questions Addressed in this Report

What is the 10-year outlook for the global Amlodipine market?

What factors are driving Amlodipine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Amlodipine market opportunities vary by end market size?

How does Amlodipine break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Amlodipine Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Amlodipine by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Amlodipine by Country/Region, 2018, 2022 & 2029
2.2 Amlodipine Segment by Type
  2.2.1 Amlodipine Benzene Sulfonate Tablet
  2.2.2 Amlodipine Mesylate Tablet
  2.2.3 Levoamlodipine Maleic Acid Tablet
2.3 Amlodipine Sales by Type
  2.3.1 Global Amlodipine Sales Market Share by Type (2018-2023)
  2.3.2 Global Amlodipine Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Amlodipine Sale Price by Type (2018-2023)
2.4 Amlodipine Segment by Application
  2.4.1 High Blood Pressure
  2.4.2 Angina Pectoris
  2.4.3 Other
2.5 Amlodipine Sales by Application
  2.5.1 Global Amlodipine Sale Market Share by Application (2018-2023)
  2.5.2 Global Amlodipine Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Amlodipine Sale Price by Application (2018-2023)

3 GLOBAL AMLODIPINE BY COMPANY

3.1 Global Amlodipine Breakdown Data by Company
  3.1.1 Global Amlodipine Annual Sales by Company (2018-2023)
  3.1.2 Global Amlodipine Sales Market Share by Company (2018-2023)
3.2 Global Amlodipine Annual Revenue by Company (2018-2023)
  3.2.1 Global Amlodipine Revenue by Company (2018-2023)
  3.2.2 Global Amlodipine Revenue Market Share by Company (2018-2023)
3.3 Global Amlodipine Sale Price by Company
3.4 Key Manufacturers Amlodipine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Amlodipine Product Location Distribution
  3.4.2 Players Amlodipine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR AMLODIPINE BY GEOGRAPHIC REGION

4.1 World Historic Amlodipine Market Size by Geographic Region (2018-2023)
  4.1.1 Global Amlodipine Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Amlodipine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Amlodipine Market Size by Country/Region (2018-2023)
  4.2.1 Global Amlodipine Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Amlodipine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Amlodipine Sales Growth
4.4 APAC Amlodipine Sales Growth
4.5 Europe Amlodipine Sales Growth
4.6 Middle East & Africa Amlodipine Sales Growth

5 AMERICAS

5.1 Americas Amlodipine Sales by Country
  5.1.1 Americas Amlodipine Sales by Country (2018-2023)
  5.1.2 Americas Amlodipine Revenue by Country (2018-2023)
5.2 Americas Amlodipine Sales by Type
5.3 Americas Amlodipine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Amlodipine Sales by Region
  6.1.1 APAC Amlodipine Sales by Region (2018-2023)
  6.1.2 APAC Amlodipine Revenue by Region (2018-2023)
6.2 APAC Amlodipine Sales by Type
6.3 APAC Amlodipine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Amlodipine by Country
  7.1.1 Europe Amlodipine Sales by Country (2018-2023)
  7.1.2 Europe Amlodipine Revenue by Country (2018-2023)
7.2 Europe Amlodipine Sales by Type
7.3 Europe Amlodipine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Amlodipine by Country
  8.1.1 Middle East & Africa Amlodipine Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Amlodipine Revenue by Country (2018-2023)
8.2 Middle East & Africa Amlodipine Sales by Type
8.3 Middle East & Africa Amlodipine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amlodipine
10.3 Manufacturing Process Analysis of Amlodipine
10.4 Industry Chain Structure of Amlodipine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Amlodipine Distributors
11.3 Amlodipine Customer

12 WORLD FORECAST REVIEW FOR AMLODIPINE BY GEOGRAPHIC REGION

12.1 Global Amlodipine Market Size Forecast by Region
  12.1.1 Global Amlodipine Forecast by Region (2024-2029)
  12.1.2 Global Amlodipine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Amlodipine Forecast by Type
12.7 Global Amlodipine Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Novartis
  13.1.1 Novartis Company Information
  13.1.2 Novartis Amlodipine Product Portfolios and Specifications
  13.1.3 Novartis Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Novartis Main Business Overview
  13.1.5 Novartis Latest Developments
13.2 Pfizer
  13.2.1 Pfizer Company Information
  13.2.2 Pfizer Amlodipine Product Portfolios and Specifications
  13.2.3 Pfizer Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Pfizer Main Business Overview
  13.2.5 Pfizer Latest Developments
13.3 Lek
  13.3.1 Lek Company Information
  13.3.2 Lek Amlodipine Product Portfolios and Specifications
  13.3.3 Lek Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Lek Main Business Overview
  13.3.5 Lek Latest Developments
13.4 TEVA
  13.4.1 TEVA Company Information
  13.4.2 TEVA Amlodipine Product Portfolios and Specifications
  13.4.3 TEVA Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 TEVA Main Business Overview
  13.4.5 TEVA Latest Developments
13.5 Macleods Pharmaceuticals
  13.5.1 Macleods Pharmaceuticals Company Information
  13.5.2 Macleods Pharmaceuticals Amlodipine Product Portfolios and Specifications
  13.5.3 Macleods Pharmaceuticals Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Macleods Pharmaceuticals Main Business Overview
  13.5.5 Macleods Pharmaceuticals Latest Developments
13.6 Caraco Pharmaceutical
  13.6.1 Caraco Pharmaceutical Company Information
  13.6.2 Caraco Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.6.3 Caraco Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Caraco Pharmaceutical Main Business Overview
  13.6.5 Caraco Pharmaceutical Latest Developments
13.7 Sanis Health
  13.7.1 Sanis Health Company Information
  13.7.2 Sanis Health Amlodipine Product Portfolios and Specifications
  13.7.3 Sanis Health Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Sanis Health Main Business Overview
  13.7.5 Sanis Health Latest Developments
13.8 Jamp Pharma
  13.8.1 Jamp Pharma Company Information
  13.8.2 Jamp Pharma Amlodipine Product Portfolios and Specifications
  13.8.3 Jamp Pharma Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Jamp Pharma Main Business Overview
  13.8.5 Jamp Pharma Latest Developments
13.9 Accel Pharma
  13.9.1 Accel Pharma Company Information
  13.9.2 Accel Pharma Amlodipine Product Portfolios and Specifications
  13.9.3 Accel Pharma Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Accel Pharma Main Business Overview
  13.9.5 Accel Pharma Latest Developments
13.10 Jubilant Generics
  13.10.1 Jubilant Generics Company Information
  13.10.2 Jubilant Generics Amlodipine Product Portfolios and Specifications
  13.10.3 Jubilant Generics Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Jubilant Generics Main Business Overview
  13.10.5 Jubilant Generics Latest Developments
13.11 Angita Pharma
  13.11.1 Angita Pharma Company Information
  13.11.2 Angita Pharma Amlodipine Product Portfolios and Specifications
  13.11.3 Angita Pharma Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Angita Pharma Main Business Overview
  13.11.5 Angita Pharma Latest Developments
13.12 Florida DOH Central Pharmacy
  13.12.1 Florida DOH Central Pharmacy Company Information
  13.12.2 Florida DOH Central Pharmacy Amlodipine Product Portfolios and Specifications
  13.12.3 Florida DOH Central Pharmacy Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Florida DOH Central Pharmacy Main Business Overview
  13.12.5 Florida DOH Central Pharmacy Latest Developments
13.13 Shanghai Disainuo Biopharmaceutical
  13.13.1 Shanghai Disainuo Biopharmaceutical Company Information
  13.13.2 Shanghai Disainuo Biopharmaceutical Amlodipine Product Portfolios and Specifications
  13.13.3 Shanghai Disainuo Biopharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Shanghai Disainuo Biopharmaceutical Main Business Overview
  13.13.5 Shanghai Disainuo Biopharmaceutical Latest Developments
13.14 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical
  13.14.1 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Company Information
  13.14.2 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.14.3 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Main Business Overview
  13.14.5 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Latest Developments
13.15 Beijing Wansheng Pharmaceutical
  13.15.1 Beijing Wansheng Pharmaceutical Company Information
  13.15.2 Beijing Wansheng Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.15.3 Beijing Wansheng Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 Beijing Wansheng Pharmaceutical Main Business Overview
  13.15.5 Beijing Wansheng Pharmaceutical Latest Developments
13.16 Beijing Honglin Pharmaceutical
  13.16.1 Beijing Honglin Pharmaceutical Company Information
  13.16.2 Beijing Honglin Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.16.3 Beijing Honglin Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.16.4 Beijing Honglin Pharmaceutical Main Business Overview
  13.16.5 Beijing Honglin Pharmaceutical Latest Developments
13.17 Beijing Maidihai Pharmaceutical
  13.17.1 Beijing Maidihai Pharmaceutical Company Information
  13.17.2 Beijing Maidihai Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.17.3 Beijing Maidihai Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.17.4 Beijing Maidihai Pharmaceutical Main Business Overview
  13.17.5 Beijing Maidihai Pharmaceutical Latest Developments
13.18 China Resources Saike Pharmaceutical
  13.18.1 China Resources Saike Pharmaceutical Company Information
  13.18.2 China Resources Saike Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.18.3 China Resources Saike Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.18.4 China Resources Saike Pharmaceutical Main Business Overview
  13.18.5 China Resources Saike Pharmaceutical Latest Developments
13.19 Beijing Jiulong Pharmaceutical
  13.19.1 Beijing Jiulong Pharmaceutical Company Information
  13.19.2 Beijing Jiulong Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.19.3 Beijing Jiulong Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.19.4 Beijing Jiulong Pharmaceutical Main Business Overview
  13.19.5 Beijing Jiulong Pharmaceutical Latest Developments
13.20 Tiannian Pharmaceutical
  13.20.1 Tiannian Pharmaceutical Company Information
  13.20.2 Tiannian Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.20.3 Tiannian Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.20.4 Tiannian Pharmaceutical Main Business Overview
  13.20.5 Tiannian Pharmaceutical Latest Developments
13.21 Chengdu Diao Pharmaceutical Group
  13.21.1 Chengdu Diao Pharmaceutical Group Company Information
  13.21.2 Chengdu Diao Pharmaceutical Group Amlodipine Product Portfolios and Specifications
  13.21.3 Chengdu Diao Pharmaceutical Group Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.21.4 Chengdu Diao Pharmaceutical Group Main Business Overview
  13.21.5 Chengdu Diao Pharmaceutical Group Latest Developments
13.22 Yangtze Pharmaceutical
  13.22.1 Yangtze Pharmaceutical Company Information
  13.22.2 Yangtze Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.22.3 Yangtze Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.22.4 Yangtze Pharmaceutical Main Business Overview
  13.22.5 Yangtze Pharmaceutical Latest Developments
13.23 Kunming Sino Pharmaceutical
  13.23.1 Kunming Sino Pharmaceutical Company Information
  13.23.2 Kunming Sino Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.23.3 Kunming Sino Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.23.4 Kunming Sino Pharmaceutical Main Business Overview
  13.23.5 Kunming Sino Pharmaceutical Latest Developments
13.24 Wuhan Dongxin Pharmaceutical Technology
  13.24.1 Wuhan Dongxin Pharmaceutical Technology Company Information
  13.24.2 Wuhan Dongxin Pharmaceutical Technology Amlodipine Product Portfolios and Specifications
  13.24.3 Wuhan Dongxin Pharmaceutical Technology Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.24.4 Wuhan Dongxin Pharmaceutical Technology Main Business Overview
  13.24.5 Wuhan Dongxin Pharmaceutical Technology Latest Developments
13.25 Jiangsu Wangao Pharmaceutical
  13.25.1 Jiangsu Wangao Pharmaceutical Company Information
  13.25.2 Jiangsu Wangao Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.25.3 Jiangsu Wangao Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.25.4 Jiangsu Wangao Pharmaceutical Main Business Overview
  13.25.5 Jiangsu Wangao Pharmaceutical Latest Developments
13.26 Jiangsu Lianhuan Pharmaceutical
  13.26.1 Jiangsu Lianhuan Pharmaceutical Company Information
  13.26.2 Jiangsu Lianhuan Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.26.3 Jiangsu Lianhuan Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.26.4 Jiangsu Lianhuan Pharmaceutical Main Business Overview
  13.26.5 Jiangsu Lianhuan Pharmaceutical Latest Developments
13.27 Jiangsu Huanghe Pharmaceutical
  13.27.1 Jiangsu Huanghe Pharmaceutical Company Information
  13.27.2 Jiangsu Huanghe Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.27.3 Jiangsu Huanghe Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.27.4 Jiangsu Huanghe Pharmaceutical Main Business Overview
  13.27.5 Jiangsu Huanghe Pharmaceutical Latest Developments
13.28 Zhejiang Jingxin Pharmaceutical
  13.28.1 Zhejiang Jingxin Pharmaceutical Company Information
  13.28.2 Zhejiang Jingxin Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.28.3 Zhejiang Jingxin Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.28.4 Zhejiang Jingxin Pharmaceutical Main Business Overview
  13.28.5 Zhejiang Jingxin Pharmaceutical Latest Developments
13.29 Zhejiang Jianfeng Pharmaceutical
  13.29.1 Zhejiang Jianfeng Pharmaceutical Company Information
  13.29.2 Zhejiang Jianfeng Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.29.3 Zhejiang Jianfeng Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.29.4 Zhejiang Jianfeng Pharmaceutical Main Business Overview
  13.29.5 Zhejiang Jianfeng Pharmaceutical Latest Developments
13.30 Hunan Qianjinxieli Pharmaceutical
  13.30.1 Hunan Qianjinxieli Pharmaceutical Company Information
  13.30.2 Hunan Qianjinxieli Pharmaceutical Amlodipine Product Portfolios and Specifications
  13.30.3 Hunan Qianjinxieli Pharmaceutical Amlodipine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.30.4 Hunan Qianjinxieli Pharmaceutical Main Business Overview
  13.30.5 Hunan Qianjinxieli Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Amlodipine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Amlodipine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Amlodipine Benzene Sulfonate Tablet
Table 4. Major Players of Amlodipine Mesylate Tablet
Table 5. Major Players of Levoamlodipine Maleic Acid Tablet
Table 6. Global Amlodipine Sales by Type (2018-2023) & (KG)
Table 7. Global Amlodipine Sales Market Share by Type (2018-2023)
Table 8. Global Amlodipine Revenue by Type (2018-2023) & ($ million)
Table 9. Global Amlodipine Revenue Market Share by Type (2018-2023)
Table 10. Global Amlodipine Sale Price by Type (2018-2023) & (US$/G)
Table 11. Global Amlodipine Sales by Application (2018-2023) & (KG)
Table 12. Global Amlodipine Sales Market Share by Application (2018-2023)
Table 13. Global Amlodipine Revenue by Application (2018-2023)
Table 14. Global Amlodipine Revenue Market Share by Application (2018-2023)
Table 15. Global Amlodipine Sale Price by Application (2018-2023) & (US$/G)
Table 16. Global Amlodipine Sales by Company (2018-2023) & (KG)
Table 17. Global Amlodipine Sales Market Share by Company (2018-2023)
Table 18. Global Amlodipine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Amlodipine Revenue Market Share by Company (2018-2023)
Table 20. Global Amlodipine Sale Price by Company (2018-2023) & (US$/G)
Table 21. Key Manufacturers Amlodipine Producing Area Distribution and Sales Area
Table 22. Players Amlodipine Products Offered
Table 23. Amlodipine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Amlodipine Sales by Geographic Region (2018-2023) & (KG)
Table 27. Global Amlodipine Sales Market Share Geographic Region (2018-2023)
Table 28. Global Amlodipine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Amlodipine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Amlodipine Sales by Country/Region (2018-2023) & (KG)
Table 31. Global Amlodipine Sales Market Share by Country/Region (2018-2023)
Table 32. Global Amlodipine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Amlodipine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Amlodipine Sales by Country (2018-2023) & (KG)
Table 35. Americas Amlodipine Sales Market Share by Country (2018-2023)
Table 36. Americas Amlodipine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Amlodipine Revenue Market Share by Country (2018-2023)
Table 38. Americas Amlodipine Sales by Type (2018-2023) & (KG)
Table 39. Americas Amlodipine Sales by Application (2018-2023) & (KG)
Table 40. APAC Amlodipine Sales by Region (2018-2023) & (KG)
Table 41. APAC Amlodipine Sales Market Share by Region (2018-2023)
Table 42. APAC Amlodipine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Amlodipine Revenue Market Share by Region (2018-2023)
Table 44. APAC Amlodipine Sales by Type (2018-2023) & (KG)
Table 45. APAC Amlodipine Sales by Application (2018-2023) & (KG)
Table 46. Europe Amlodipine Sales by Country (2018-2023) & (KG)
Table 47. Europe Amlodipine Sales Market Share by Country (2018-2023)
Table 48. Europe Amlodipine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Amlodipine Revenue Market Share by Country (2018-2023)
Table 50. Europe Amlodipine Sales by Type (2018-2023) & (KG)
Table 51. Europe Amlodipine Sales by Application (2018-2023) & (KG)
Table 52. Middle East & Africa Amlodipine Sales by Country (2018-2023) & (KG)
Table 53. Middle East & Africa Amlodipine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Amlodipine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Amlodipine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Amlodipine Sales by Type (2018-2023) & (KG)
Table 57. Middle East & Africa Amlodipine Sales by Application (2018-2023) & (KG)
Table 58. Key Market Drivers & Growth Opportunities of Amlodipine
Table 59. Key Market Challenges & Risks of Amlodipine
Table 60. Key Industry Trends of Amlodipine
Table 61. Amlodipine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Amlodipine Distributors List
Table 64. Amlodipine Customer List
Table 65. Global Amlodipine Sales Forecast by Region (2024-2029) & (KG)
Table 66. Global Amlodipine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Amlodipine Sales Forecast by Country (2024-2029) & (KG)
Table 68. Americas Amlodipine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Amlodipine Sales Forecast by Region (2024-2029) & (KG)
Table 70. APAC Amlodipine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Amlodipine Sales Forecast by Country (2024-2029) & (KG)
Table 72. Europe Amlodipine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Amlodipine Sales Forecast by Country (2024-2029) & (KG)
Table 74. Middle East & Africa Amlodipine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Amlodipine Sales Forecast by Type (2024-2029) & (KG)
Table 76. Global Amlodipine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Amlodipine Sales Forecast by Application (2024-2029) & (KG)
Table 78. Global Amlodipine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Novartis Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Amlodipine Product Portfolios and Specifications
Table 81. Novartis Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. Pfizer Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Amlodipine Product Portfolios and Specifications
Table 86. Pfizer Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 87. Pfizer Main Business
Table 88. Pfizer Latest Developments
Table 89. Lek Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 90. Lek Amlodipine Product Portfolios and Specifications
Table 91. Lek Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 92. Lek Main Business
Table 93. Lek Latest Developments
Table 94. TEVA Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 95. TEVA Amlodipine Product Portfolios and Specifications
Table 96. TEVA Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 97. TEVA Main Business
Table 98. TEVA Latest Developments
Table 99. Macleods Pharmaceuticals Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 100. Macleods Pharmaceuticals Amlodipine Product Portfolios and Specifications
Table 101. Macleods Pharmaceuticals Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 102. Macleods Pharmaceuticals Main Business
Table 103. Macleods Pharmaceuticals Latest Developments
Table 104. Caraco Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 105. Caraco Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 106. Caraco Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 107. Caraco Pharmaceutical Main Business
Table 108. Caraco Pharmaceutical Latest Developments
Table 109. Sanis Health Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 110. Sanis Health Amlodipine Product Portfolios and Specifications
Table 111. Sanis Health Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 112. Sanis Health Main Business
Table 113. Sanis Health Latest Developments
Table 114. Jamp Pharma Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 115. Jamp Pharma Amlodipine Product Portfolios and Specifications
Table 116. Jamp Pharma Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 117. Jamp Pharma Main Business
Table 118. Jamp Pharma Latest Developments
Table 119. Accel Pharma Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 120. Accel Pharma Amlodipine Product Portfolios and Specifications
Table 121. Accel Pharma Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 122. Accel Pharma Main Business
Table 123. Accel Pharma Latest Developments
Table 124. Jubilant Generics Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 125. Jubilant Generics Amlodipine Product Portfolios and Specifications
Table 126. Jubilant Generics Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 127. Jubilant Generics Main Business
Table 128. Jubilant Generics Latest Developments
Table 129. Angita Pharma Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 130. Angita Pharma Amlodipine Product Portfolios and Specifications
Table 131. Angita Pharma Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 132. Angita Pharma Main Business
Table 133. Angita Pharma Latest Developments
Table 134. Florida DOH Central Pharmacy Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 135. Florida DOH Central Pharmacy Amlodipine Product Portfolios and Specifications
Table 136. Florida DOH Central Pharmacy Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 137. Florida DOH Central Pharmacy Main Business
Table 138. Florida DOH Central Pharmacy Latest Developments
Table 139. Shanghai Disainuo Biopharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 140. Shanghai Disainuo Biopharmaceutical Amlodipine Product Portfolios and Specifications
Table 141. Shanghai Disainuo Biopharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 142. Shanghai Disainuo Biopharmaceutical Main Business
Table 143. Shanghai Disainuo Biopharmaceutical Latest Developments
Table 144. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 145. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 146. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 147. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Main Business
Table 148. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Latest Developments
Table 149. Beijing Wansheng Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 150. Beijing Wansheng Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 151. Beijing Wansheng Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 152. Beijing Wansheng Pharmaceutical Main Business
Table 153. Beijing Wansheng Pharmaceutical Latest Developments
Table 154. Beijing Honglin Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 155. Beijing Honglin Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 156. Beijing Honglin Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 157. Beijing Honglin Pharmaceutical Main Business
Table 158. Beijing Honglin Pharmaceutical Latest Developments
Table 159. Beijing Maidihai Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 160. Beijing Maidihai Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 161. Beijing Maidihai Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 162. Beijing Maidihai Pharmaceutical Main Business
Table 163. Beijing Maidihai Pharmaceutical Latest Developments
Table 164. China Resources Saike Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 165. China Resources Saike Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 166. China Resources Saike Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 167. China Resources Saike Pharmaceutical Main Business
Table 168. China Resources Saike Pharmaceutical Latest Developments
Table 169. Beijing Jiulong Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 170. Beijing Jiulong Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 171. Beijing Jiulong Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 172. Beijing Jiulong Pharmaceutical Main Business
Table 173. Beijing Jiulong Pharmaceutical Latest Developments
Table 174. Tiannian Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 175. Tiannian Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 176. Tiannian Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 177. Tiannian Pharmaceutical Main Business
Table 178. Tiannian Pharmaceutical Latest Developments
Table 179. Chengdu Diao Pharmaceutical Group Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 180. Chengdu Diao Pharmaceutical Group Amlodipine Product Portfolios and Specifications
Table 181. Chengdu Diao Pharmaceutical Group Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 182. Chengdu Diao Pharmaceutical Group Main Business
Table 183. Chengdu Diao Pharmaceutical Group Latest Developments
Table 184. Yangtze Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 185. Yangtze Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 186. Yangtze Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 187. Yangtze Pharmaceutical Main Business
Table 188. Yangtze Pharmaceutical Latest Developments
Table 189. Kunming Sino Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 190. Kunming Sino Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 191. Kunming Sino Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 192. Kunming Sino Pharmaceutical Main Business
Table 193. Kunming Sino Pharmaceutical Latest Developments
Table 194. Wuhan Dongxin Pharmaceutical Technology Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 195. Wuhan Dongxin Pharmaceutical Technology Amlodipine Product Portfolios and Specifications
Table 196. Wuhan Dongxin Pharmaceutical Technology Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 197. Wuhan Dongxin Pharmaceutical Technology Main Business
Table 198. Wuhan Dongxin Pharmaceutical Technology Latest Developments
Table 199. Jiangsu Wangao Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 200. Jiangsu Wangao Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 201. Jiangsu Wangao Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 202. Jiangsu Wangao Pharmaceutical Main Business
Table 203. Jiangsu Wangao Pharmaceutical Latest Developments
Table 204. Jiangsu Lianhuan Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 205. Jiangsu Lianhuan Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 206. Jiangsu Lianhuan Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 207. Jiangsu Lianhuan Pharmaceutical Main Business
Table 208. Jiangsu Lianhuan Pharmaceutical Latest Developments
Table 209. Jiangsu Huanghe Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 210. Jiangsu Huanghe Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 211. Jiangsu Huanghe Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 212. Jiangsu Huanghe Pharmaceutical Main Business
Table 213. Jiangsu Huanghe Pharmaceutical Latest Developments
Table 214. Zhejiang Jingxin Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 215. Zhejiang Jingxin Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 216. Zhejiang Jingxin Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 217. Zhejiang Jingxin Pharmaceutical Main Business
Table 218. Zhejiang Jingxin Pharmaceutical Latest Developments
Table 219. Zhejiang Jianfeng Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 220. Zhejiang Jianfeng Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 221. Zhejiang Jianfeng Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 222. Zhejiang Jianfeng Pharmaceutical Main Business
Table 223. Zhejiang Jianfeng Pharmaceutical Latest Developments
Table 224. Hunan Qianjinxieli Pharmaceutical Basic Information, Amlodipine Manufacturing Base, Sales Area and Its Competitors
Table 225. Hunan Qianjinxieli Pharmaceutical Amlodipine Product Portfolios and Specifications
Table 226. Hunan Qianjinxieli Pharmaceutical Amlodipine Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 227. Hunan Qianjinxieli Pharmaceutical Main Business
Table 228. Hunan Qianjinxieli Pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Picture of Amlodipine
Figure 2. Amlodipine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amlodipine Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Amlodipine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Amlodipine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Amlodipine Benzene Sulfonate Tablet
Figure 10. Product Picture of Amlodipine Mesylate Tablet
Figure 11. Product Picture of Levoamlodipine Maleic Acid Tablet
Figure 12. Global Amlodipine Sales Market Share by Type in 2022
Figure 13. Global Amlodipine Revenue Market Share by Type (2018-2023)
Figure 14. Amlodipine Consumed in High Blood Pressure
Figure 15. Global Amlodipine Market: High Blood Pressure (2018-2023) & (KG)
Figure 16. Amlodipine Consumed in Angina Pectoris
Figure 17. Global Amlodipine Market: Angina Pectoris (2018-2023) & (KG)
Figure 18. Amlodipine Consumed in Other
Figure 19. Global Amlodipine Market: Other (2018-2023) & (KG)
Figure 20. Global Amlodipine Sales Market Share by Application (2022)
Figure 21. Global Amlodipine Revenue Market Share by Application in 2022
Figure 22. Amlodipine Sales Market by Company in 2022 (KG)
Figure 23. Global Amlodipine Sales Market Share by Company in 2022
Figure 24. Amlodipine Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Amlodipine Revenue Market Share by Company in 2022
Figure 26. Global Amlodipine Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Amlodipine Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Amlodipine Sales 2018-2023 (KG)
Figure 29. Americas Amlodipine Revenue 2018-2023 ($ Millions)
Figure 30. APAC Amlodipine Sales 2018-2023 (KG)
Figure 31. APAC Amlodipine Revenue 2018-2023 ($ Millions)
Figure 32. Europe Amlodipine Sales 2018-2023 (KG)
Figure 33. Europe Amlodipine Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Amlodipine Sales 2018-2023 (KG)
Figure 35. Middle East & Africa Amlodipine Revenue 2018-2023 ($ Millions)
Figure 36. Americas Amlodipine Sales Market Share by Country in 2022
Figure 37. Americas Amlodipine Revenue Market Share by Country in 2022
Figure 38. Americas Amlodipine Sales Market Share by Type (2018-2023)
Figure 39. Americas Amlodipine Sales Market Share by Application (2018-2023)
Figure 40. United States Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Amlodipine Sales Market Share by Region in 2022
Figure 45. APAC Amlodipine Revenue Market Share by Regions in 2022
Figure 46. APAC Amlodipine Sales Market Share by Type (2018-2023)
Figure 47. APAC Amlodipine Sales Market Share by Application (2018-2023)
Figure 48. China Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Amlodipine Sales Market Share by Country in 2022
Figure 56. Europe Amlodipine Revenue Market Share by Country in 2022
Figure 57. Europe Amlodipine Sales Market Share by Type (2018-2023)
Figure 58. Europe Amlodipine Sales Market Share by Application (2018-2023)
Figure 59. Germany Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Amlodipine Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Amlodipine Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Amlodipine Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Amlodipine Sales Market Share by Application (2018-2023)
Figure 68. Egypt Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Amlodipine Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Amlodipine in 2022
Figure 74. Manufacturing Process Analysis of Amlodipine
Figure 75. Industry Chain Structure of Amlodipine
Figure 76. Channels of Distribution
Figure 77. Global Amlodipine Sales Market Forecast by Region (2024-2029)
Figure 78. Global Amlodipine Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Amlodipine Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Amlodipine Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Amlodipine Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Amlodipine Revenue Market Share Forecast by Application (2024-2029)


More Publications